Skip to main content
logo
HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
3.270
-0.140 (-4.11%)
At close: Aug 10, 2026, 4:00 PM EDT
3.340
+0.070 (2.14%)
After-hours: Aug 10, 2026, 7:18 PM EDT

HCW Biologics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
4320446983
Market Cap Growth
-52.38%-83.97%-55.17%-35.50%-17.22%-
Enterprise Value
9.258.0428.8847.0243.0446.27
Last Close Price
3.275.82107.04295.20459.54556.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.6558.707.7415.5910.22-
PB Ratio
0.661.15-2.933.291.841.62
P/TBV Ratio
0.300.74-3.281.830.85

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
1.46148.2511.2516.556.40-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.142.46-2.020.470.170
Net Debt / Equity Ratio
0.931.76-1.330.20-0.68-0.72
Net Debt / EBITDA Ratio
-0.74-0.40-0.32-0.111.792.86
Net Debt / FCF Ratio
-0.47-0.36-0.62-0.091.243.33
Asset Turnover
0.250.000.090.080.130
Quick Ratio
0.070.090.180.5910.9915.87
Current Ratio
0.090.110.190.7311.5217.44
Return on Equity (ROE)
-53.72%397.45%-897.37%-98.23%-33.63%-39.22%
Return on Assets (ROA)
-28.11%-48.08%-100.28%-68.29%-30.06%-38.80%
Return on Invested Capital (ROIC)
-77.83%-319.90%-351.12%-184.04%-114.86%-130.93%
Return on Capital Employed (ROCE)
-147.27%-647.60%-289.16%-80.85%-31.73%-40.76%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-212.37%-116.30%-7.97%-0.30%-90.84%-296.07%
Total Shareholder Return
-212.37%-116.30%-7.97%-0.30%-90.84%-296.07%
SEC Filings: 10-K · 10-Q